Jun 04 Watch 8:47 FDA panel rejects attempt to use psychedelic drug for PTSD treatment By Miles O'Brien, Karina Cuevas and Caleb Hellerman, Global Health Reporting Center A key FDA advisory committee rejected the use of a psychedelic drug to help patients struggling with PTSD, questioning its safety and effectiveness. The FDA must now decide whether it will follow suit and reject the use of what's known… Continue watching
Jun 04 WATCH: FDA expert panel rejects psychedelic drug MDMA as a PTSD treatment By Matthew Perrone, Associated Press The panel of advisers to the Food and Drug Administration cited flawed study data, questionable research conduct and significant drug risks, including the potential for heart problems, injury and abuse. Continue reading
May 31 Psychedelic drug MDMA faces questions as FDA considers approval for PTSD By Matthew Perrone, Associated Press The Food and Drug Administration posted its review of the drug on Friday, raising questions about its effectiveness and potential risks, including heart problems. Continue reading
Apr 29 FDA brings lab tests under federal oversight in bid to improve accuracy and safety By Matthew Perrone, Associated Press The FDA has warned for years that inaccurate test results can lead to unnecessary treatment and delays in getting proper care. Under the new requirements, labs will have about four years to win FDA approval for new tests. Continue reading
Apr 26 Biden administration indefinitely delays potential ban on menthol cigarettes By Matthew Perrone, Zeke Miller, Associated Press The announcement is another setback for Food and Drug Administration officials, who drafted the ban and predicted it would prevent hundreds of thousands of smoking-related deaths over 40 years. Continue reading
Mar 26 5 takeaways from the abortion pill case before the U.S. Supreme Court By Matthew Perrone, Amanda Seitz, Christine Fernando, Associated Press U.S. Supreme Court justices on Tuesday did not appear ready to limit Americans’ access to the abortion pill mifepristone, in a case that could have sweeping implications for how the federal government approves scores of medications. Continue reading
Mar 04 First over-the-counter birth control pill in U.S. begins shipping to stores By Matthew Perrone, Associated Press The pill is a hormone-based contraceptive, similar to drugs used by millions of U.S. women for decades. Birth control pills are available without a prescription across much of South America, Asia and Africa. Continue reading
Feb 17 Watch 3:22 News Wrap: Navalny’s mother pushes for answers after his death in prison In our news wrap Saturday, Alexei Navalny’s mother is pressing for details of how the Russian opposition leader died in an Arctic penal colony, outnumbered Ukrainian forces have withdrawn from the devastated eastern city of Avdiivka, U.S. Secretary of State… Continue watching
Feb 13 Watch 7:21 FDA warns addictive ‘gas station heroin’ supplement widely available in U.S. By Ali Rogin, Courtney Norris The Food and Drug Administration has issued warnings about a potentially addictive dietary supplement that’s widely available in the U.S. "Neptune’s Fix" is often sold as a supplement and features an ingredient called tianeptine, popularly known as "gas-station heroin." Ali… Continue watching
Jan 21 Watch 5:46 Lead-contaminated applesauce pouches expose issues with food safety oversight By John Yang, Andrew Corkery, Claire Mufson, Juliet Fuisz The effects of an Oct. 2023 recall of applesauce pouches with high concentrations of lead are widening, raising questions about how food reaches store shelves, who watches over it and how far that oversight extends. Helena Bottemiller Evich, founder and… Continue watching